TOKYO, February 12, 2020 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced today that its “Annual Report 2018” published in March 2019 has won Second Prize for the second consecutive year in the 22nd NIKKEI Annual Report Awards.

Started by Nikkei Inc. in 1998, the NIKKEI Annual Report Awards are presented with the aim to further enhance and promote annual reports published by Japanese companies. This year, 133 companies participated, significantly exceeding the number in the previous year, and a Grand Prize, three Second Prizes, two Special Prizes, and 14 Honors were awarded. 

Chugai began integrated reporting from Annual Report 2012 and has made various efforts to promote a better understanding of its unique strengths and corporate value among a wide range of stakeholders. As a result, our report has continually earned high acclaim, receiving an award every year since 2012, and winning the Grand Prize for two consecutive years in 2014 and 2015. 

Chugai’s Annual Report 2018 was highly evaluated for “containing a very high quality description of the core components of integrated reporting such as vision, business model, strategy, risk and opportunity, performance, governance, sustainability, and the reason for creating the new mid-term business plan. The report also explained the company’s relationship with the majority shareholder and how it ensures the rights and equality of shareholders.” 

In addition, Chugai’s Annual Report has been awarded a Prize for Excellence in Integrated Reporting in the 7th WICI Japan Award for Excellence in Integrated Reporting, marking the first time Chugai has been a double award winner. 

Chugai will continue striving to disclose information in an easy-to-understand manner in order to help satisfy the needs of its many stakeholders.

“Annual Report 2018” can be viewed from the following page:
https://www.chugai-pharm.co.jp/english/ir/reports_downloads/annual_reports.html